BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Ardana Plc Release: Suspension of Shares for Trading on the Official List, Entry into Voluntary Administration


6/30/2008 1:20:13 PM

Edinburgh, 30 June 2008: Ardana PLC announces that, at its own request, trading in the Company's ordinary shares was suspended with effect from 16.25 on Friday 27 June 2008, following which the Board has agreed to appoint Mr David Duggins and Mr Tom Burton of Ernst & Young LLP to act as Administrators of the Company from today.

The Board of Ardana has taken these steps after it became apparent that a possible refinancing or a possible sale or merger under discussion could not be completed within a timeframe during which the Board believed the Company would have sufficient cash reserves to continue trading. All discussions were terminated by the afternoon of Friday 27 June.

The Company has over recent months been in a number of licensing discussions for individual development products, however the Board have also concluded that these potential transactions could not be completed within the time available before exhaustion of the Company's cash resources.

As a result, the Board of Ardana has taken advice and with great regret no longer believes that the Company is in a position to continue its operations. It is expected that the appointment of administrators will formally occur later today, following which the Administrator will take such measures as they believe appropriate including continuing to seek a buyer for the Company and its assets.

For further information please call:

Mr David Duggins, Ernst & Young LLP
One Colmore Square, Birmingham, B4 6HQ, United Kingdom
Telephone: +44 (0)121 535 2656

Press Enquiries:

Michelle Wolf, Ernst & Young LLP
Telephone: +44 (0)207 980 0043



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES